Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Methadone Treatment-As-Usual

Phase 3Small molecule

FFriends Research Institute, Inc.

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Substance UseRecruiting

Substance UsePhase 3

Recruiting

Timeline

Expected Milestones

Q3 2027

Phase 3Recruiting

Substance Use

NCT05766631

Clinical

Trials by Indication[1]

Substance Use1 trial

Treating Polysubstance Use Using a Novel Digital Technology

Recruiting·FFriends Research Institute, Inc.·Phase 3·NCT05766631·240 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Methadone Treatment-As-Usual. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Methadone Treatment-As-Usual compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Methadone Treatment-As-Usual. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Friends Research Institute, Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: FFriends Research Institute, Inc.

Related News